Filing Details
- Accession Number:
- 0001209191-23-009875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-15 18:41:12
- Reporting Period:
- 2023-02-13
- Accepted Time:
- 2023-02-15 18:41:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1308547 | Dolby Laboratories Inc. | DLB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200469 | J Kevin Yeaman | C/O Dolby Laboratories, Inc. 1275 Market Street San Francisco CA 94103 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2023-02-14 | 30,780 | $45.50 | 82,659 | No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Class A Common Stock | Disposition | 2023-02-14 | 17,336 | $83.28 | 65,323 | No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Class A Common Stock | Disposition | 2023-02-14 | 13,444 | $83.76 | 51,879 | No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
No | 4 | S | Indirect | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-02-13 | 98,200 | $0.00 | 98,200 | $71.07 |
Class A Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2023-02-13 | 98,200 | $0.00 | 98,200 | $71.07 |
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-02-14 | 30,780 | $0.00 | 30,780 | $45.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2032-12-15 | No | 5 | G | Direct | |
98,200 | 2032-12-15 | No | 5 | G | Indirect | |
61,559 | 2023-12-15 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 119,557 | Direct |
Footnotes
- The shares were sold in multiple transactions at prices ranging from $82.67 to $83.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares were sold in multiple transactions at prices ranging from $83.67 to $83.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares held following the reported transactions include 119,557 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- Effective February 13, 2023 the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.
- This option was granted for a total of 98,200 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
- This performance-based stock option award was granted for a total of 97,199 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 92,339 shares.